DistantNews
Support us

Kim Seung-won Says He Will Address Drug-Trial Solicitation and Slush-Fund Allegations at Hearing

From Dong-A Ilbo · () Korean

Translated from Korean and summarized by DistantNews. Read the original for the full story.

At a glance

News Named sources In the courts
  • Justice minister nominee Kim Seung-won said he would fully explain allegations involving a COVID-19 treatment trial and alleged slush-fund creation at his confirmation hearing.
  • Kim maintained that he conveyed a public-interest grievance rather than soliciting approval for a treatment, and noted that prosecutors issued a deferred indictment in the case.
  • The National Assembly hearing is scheduled for June 15.

Kim Seung-won, President Lee Jae-myung’s nominee for justice minister, said he would explain the allegations surrounding him at his parliamentary confirmation hearing, but offered few details to reporters.

I will explain it in detail at the hearing.

· Kim Seung-wonKim’s response to reporters asking about the allegations against him.

Speaking to journalists on June 8 as he arrived at an office in Seoul’s Jongno district to prepare for the hearing, Kim repeatedly said he would address the matter there. The allegations include soliciting approval for a clinical trial of a COVID-19 treatment and creating a slush fund during his time as head of the Democratic Party’s Gyeonggi provincial branch.

Kim has maintained that he did not ask officials to approve a treatment. Instead, he says he conveyed a public-interest grievance. He also emphasized that prosecutors gave him a deferred indictment in connection with the allegation involving the COVID-19 treatment trial.

I will explain it well at the hearing.

· Kim Seung-wonKim repeated that he would address the allegations during the confirmation hearing.

The National Assembly confirmation hearing is scheduled for June 15.

I did not solicit approval for the treatment. I conveyed a public-interest grievance.

· Kim Seung-wonKim’s stated position on the allegation involving approval for a COVID-19 treatment trial.
About this summary

Originally published by Dong-A Ilbo in Korean. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.